Literature DB >> 12403984

Miracles and molecules--progress in spinal cord repair.

Andrew R Blight1.   

Abstract

Severe spinal cord injury (SCI) leads to devastating loss of neurological function below the level of injury and adversely affects multiple body systems. Most basic research on SCI is designed to find ways to improve the unsatisfactory cellular and molecular responses of spinal cord to injury, which include an array of early processes of autodestruction and a subsequent lack of functional tissue repair. This research has brought us to the threshold of practical application along three lines of approach, derived from animal model studies: acute neuroprotection, enhanced axonal regeneration or plasticity, and treatment of demyelination. There is a growing commercial interest in this previously neglected therapeutic area.

Entities:  

Mesh:

Year:  2002        PMID: 12403984     DOI: 10.1038/nn939

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  29 in total

1.  Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice.

Authors:  Jun Li; Yanbin Liu; Haidong Xu; Qiang Fu
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

Review 2.  Failed central nervous system regeneration: a downside of immune privilege?

Authors:  Ingo Bechmann
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 3.  From stem cells to oligodendrocytes: prospects for brain therapy.

Authors:  Cui P Chen; Mary E Kiel; Dorota Sadowski; Randall D McKinnon
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

4.  G. Heiner Sell memorial lecture: neuronal plasticity after spinal cord injury: significance for present and future treatments.

Authors:  Volker Dietz
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

5.  Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells.

Authors:  Qilin Cao; Xiao-Ming Xu; William H Devries; Gaby U Enzmann; Peipei Ping; Pantelis Tsoulfas; Patrick M Wood; Mary Bartlett Bunge; Scott R Whittemore
Journal:  J Neurosci       Date:  2005-07-27       Impact factor: 6.167

6.  The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury.

Authors:  Laura E Gonzalez-Lara; Xiaoyun Xu; Klara Hofstetrova; Anna Pniak; Yuhua Chen; Catherine D McFadden; Francisco M Martinez-Santiesteban; Brian K Rutt; Arthur Brown; Paula J Foster
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

7.  Axonal remyelination by cord blood stem cells after spinal cord injury.

Authors:  Venkata Ramesh Dasari; Daniel G Spomar; Christopher S Gondi; Christopher A Sloffer; Kay L Saving; Meena Gujrati; Jasti S Rao; Dzung H Dinh
Journal:  J Neurotrauma       Date:  2007-02       Impact factor: 5.269

8.  Neuroprotective effect of anthocyanin on experimental traumatic spinal cord injury.

Authors:  Kyoung-Tae Kim; Taek-Kyun Nam; Yong-Sook Park; Young-Baeg Kim; Seung-Won Park
Journal:  J Korean Neurosurg Soc       Date:  2011-04-30

9.  Bone marrow stem cells delivered into the subarachnoid space via cisterna magna improve repair of injured rat spinal cord white matter.

Authors:  Wiesław Marcol; Wojciech Slusarczyk; Aleksander L Sieroń; Halina Koryciak-Komarska; Joanna Lewin-Kowalik
Journal:  Int J Clin Exp Med       Date:  2015-09-15

10.  Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury.

Authors:  Wei Rong; Jun Wang; Xiaoguang Liu; Liang Jiang; Feng Wei; Xing Hu; Xiaoguang Han; Zhongjun Liu
Journal:  Neurochem Res       Date:  2012-03-28       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.